In vitro ACE2 spike RBD (SARS-CoV-2) inhibitory effect of compounds 1–4 compared to quercetin.

Saved in:

Bibliographic Details
Main Author:	Fatma A. Moharram (9276104) (author)
Other Authors:	Reham R. Ibrahim (6245684) (author), Shahenda Mahgoub (9276101) (author), Mohamed S. Abdel-Aziz (1773328) (author), Ahmed M. Said (11857965) (author), Hui-Chi Huang (180405) (author), Lo-Yun Chen (13036731) (author), Kuei-Hung Lai (3226101) (author), Nashwa Hashad (20614651) (author), Mohamed S. Mady (13151892) (author)
Published:	2025
Subjects:	Biochemistry Microbiology Cell Biology Pharmacology Biotechnology Immunology Cancer Infectious Diseases Virology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified treated raw 264 div >< p deoxyrubralactone (< b alternariol (< b altenuline (< b tnfr2 inhibitory activity inhibitory activity confirmed 7 macrophage cells two novel compounds 1 &# 8211 4 </ b alternaria alternate </ immunoblotting analysis confirmed 2 </ b alternate </ silico analysis inhibitory effect endothelial cells 2 inhibitory vitro </ via </ viral agents variable degrees therapeutic tactics studies showed stimulated monocytes spike rbd proinflammatory cytokines molecular docking like potential inflammatory potentials inflammatory potential inflammatory activities first time developing preventative based assay assessed using 5 -< 2 infection 2 expression 2 attachment
Tags:	Add Tag No Tags, Be the first to tag this record!

<i>In vitro</i> ACE2 spike RBD (SARS-CoV-2) inhibitory effect of compounds 1–4 compared to quercetin.